Prostate-specific antigen screening for prostate cancer in older men in the United States of America

Gerontology

Volumn 58, Issue 4, 2012, Pages 331-336

  Black, Amanda ^a   Berg, Christine D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Older men; Prostate cancer; Prostate cancer mortality; Prostate specific antigen; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AGING; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SCREENING; CLINICAL PRACTICE; DISEASE COURSE; GERIATRIC PATIENT; HUMAN; LABORATORY TEST; MALE; MEN'S HEALTH; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; UNITED STATES; WATCHFUL WAITING;

AGED; EARLY DETECTION OF CANCER; HUMANS; LIFE EXPECTANCY; MALE; PRACTICE GUIDELINES AS TOPIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; UNITED STATES;

EID: 84863315546     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000334242     Document Type: Article

References (37)

1. Jemal A, Siegel R, Xu J, Ward E: Cancer Statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Adolfsson J: Commentary: on the incidence of histological prostate cancer and the probable diagnosis of cases with tumours too small to produce symptoms or to attract attention on physical examination - the findings of Dr Arnold Rice Rich. Int J Epidemiol 2007; 36: 285-287.
3. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK (eds): SEER Cancer Statistics Review, 1975-2007. Bethesda, National Cancer Institute. ht tp://seer.cancer.gov/ csr/1975-2007/ (based on November 2009 SEER data submission, posted to the SEER web site 2010).
4. National Center for Health Statistics: Health, United States, 2008, with Chartbook. National Center for Health Statistics, Hyattsville, 2009.
5. Johansson JE, Holmberg L, Johansson S, Bergström R, Adami HO: Fifteen-year survival in prostate cancer. A prospective, population- based study in Sweden. JAMA 1997; 277: 467-471.
6. US Census Bureau website. www.census.gov (accessed August 4, 2010).
7. Wolf AMD, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, Brooks DD, Dash C, Guessous I, Andrews K, DeSantis C, Smith RA; American Cancer Society Prostate Cancer Advisory Committee: American Cancer Society Guideline for the Early Detection of Prostate Cancer: update 2010. CA Cancer J Clin 2010; 60: 70-98.
8. American Urological Association: Prostate- Specific Antigen Best Practice Statement: 2009 Update. 2009. http://www.auanet.org/ content/guidelines-and- quality-care/clinical- guidelines/main-reports/psa09.pdf.
9. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Prostate Cancer. http://img.medscape.com/ article/715/312/ProstateV.1- 2010(Medscape). pdf.
10. US Preventive Services Task Force: Screening for Prostate Cancer. Recommendation Statement. http://www.uspreventiveservicestaskforce. org/uspstf08/prostate/prostaters. htm.
11. Schröder F, Hugosson J, Roobol M, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators: Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-1328.
12. Andriole G, Crawford E, Grubb R III, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD; PLCO Project Team: Mortality results from a randomized prostate- cancer screening trial. N Engl J Med 2009; 360: 1310-1319.
13. Pinsky PF, Black A, Kramer B, Miller A, Prorok PC, Berg C: Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Clin Trials 2010; 7: 303-311.
14. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL: Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008; 148: 435-448.
15. Shao YH, Albertsen PC, Roberts CB, Lin Y, Mehta AR, Stein MN, DiPaola RS, Lu-Yao GL: Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/ml. Arch Intern Med 2010; 170: 1256-1261.
16. Carlsson S, Adolfsson J, Bratt O, Johansson JE, Ahlstrand C, Holmberg E, Stattin P, Hugosson J: Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden. Scand J Urol Nephrol 2009; 43: 350-356.
17. Alibhai SMH, Leach M, Tomlinson G, Krahn MD, Fleshner N, Holowaty E, Naglie G: 30- day mortality and major complications after radical prostatectomy: influence of age and comorbidity. J Natl Cancer Inst 2005; 97: 1525-1532.
18. Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulati R, Feuer E, de Koning H: Lead time and overdiagnosis in prostatespecific antigen screening: importance of methods and context. J Natl Cancer Inst 2009; 101: 374-383.
19. Hoffman KE, Nguyen PL, Ng AK, D'Amico AV: Prostate cancer screening in men 75 years older or older: an assessment of selfreported health status and life expectancy. J Urol 2010; 183: 1798-1802.
20. Sirovich BE, Schwartz LM, Woloshin S: Screening men for prostate and colorectal cancer in the United States. JAMA 2003; 289: 1414-1420.
21. Li J, Zhao G, Pollack LA, Smith JL, Joseph DA: Use of the prostate-specific antigen test among men aged 75 years or older in the United States: 2006 Behavioral Risk Factor Surveillance System. Prev Chronic Dis 2010; 7:A84.
22. Walter LC, Berenthal D, Lindquist K, Konety BR: PSA screening among elderly men with limited life expectancies. JAMA 2006; 296: 2336-2342.
23. Hudson SV, Ohman-Strickland P, Ferrante JM, Lu-Yao G, Orzano AJ, Crabtree BF: Prostate- specific antigen testing among the elderly in community-based family medicine practices. J Am Board Fam Med 2009; 22: 257-265.
24. Steele CB, Miller DS, Maylahn C, Uhler RJ, Baker CT: Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health 2000; 90: 1595-1600.
25. Lu-Yao G, Stukel TA, Yao S-L: Prostate-specific antigen screening in elderly men. J Natl Cancer Inst 2003; 95: 1792-1797.
26. Merenstein D: A piece of my mind. Winners and losers. JAMA 2004; 291: 15-16.
27. So W: Incentives change prostate specific antigen testing in VA hospitals (abstract P12). American Geriatrics Society 2010 Annual Scientific Meeting, Lake Buena Vista, Fla., 2010.
28. Anderson RN: US decennial life tables for 1989-91, vol 1, No 4. United States life tables eliminating certain causes of death. Hyattsville, National Center for Health Statistics, 1999.
29. Albertsen PC, Hanley JA, Gleason DF, Barry MJ: Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 1998; 280: 975-980.
30. Johansson JE, Adami HO, Andersson SO, Bergström R, Holmberg L, Krusemo UB: High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA 1992; 267: 2191-2196.
31. Fouad MN, Mayo CP, Funkhouser EM, Irene Hall H, Urban DA, Kiefe CI: Comorbidity independently predicted death in older prostate cancer patients, more of whom died with than from their disease. J Clin Epidemiol 2004; 57: 721-729.
32. Walter LC, Covinsky KE: Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001; 285: 2750-2756.
33. Pinsky PF: Antioxidant supplementation and cancer prevention. JAMA 2009; 301: 1878.
34. Bill-Axelson A, Holmberg L, Filen F, Ruutu M, Garmo H, Busch C, Nordling S, Häggman M, Andersson SO, Bratell S, Spångberg A, Palmgren J, Adami HO, Johansson JE; Scandinavian Prostate Cancer Group Study Number 4: Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian Prostate Cancer Group-4 Randomized Trial. J Natl Cancer Inst 2008; 100: 1144-1154.
35. Alibhai SM, Naglie G, Nam R, Trachtenberg J, Krahn MD: Do older men benefit from curative therapy for localized prostate cancer? J Clin Oncol 2003; 21: 3318-3127.
36. Crawford ED, Grubb R 3rd, Black A, Andriole GL Jr, Chen MH, Izmirlian G, Berg CD, D'Amico AV: Comorbidity and mortality results from a randomized prostate cancer screening trial. J Clin Oncol 2011; 29: 355-361.
37. Woloshin S, Schwartz LM, Welch HG: The risk of death by age, sex, and smoking status in the United States: putting health risks in context. J Natl Cancer Inst 2008; 100: 845-853.